CLU and Alzheimer disease: Based on the above, molecules containing A2Macro, α1 antitrypsin, ApoE, AAT, complement C3, clusterin, and TNF‐α were able to be duplicated in different experiments and seemed to be as a novel plasma‐based protein panel for AD prediction.